PARP11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.044400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.481610E-01
Normal-vs-Stage2
8.665600E-02
Normal-vs-Stage3
6.624400E-02
Normal-vs-Stage4
1.536840E-01
Stage1-vs-Stage2
7.835600E-01
Stage1-vs-Stage3
1.611780E-01
Stage1-vs-Stage4
7.199600E-01
Stage2-vs-Stage3
4.586800E-01
Stage2-vs-Stage4
9.867800E-01
Stage3-vs-Stage4
2.066000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.043240E-01
Normal-vs-AfricanAmerican
1.170220E-01
Normal-vs-Asian
1.557010E-01
Caucasian-vs-AfricanAmerican
7.217400E-01
Caucasian-vs-Asian
3.900600E-03
AfricanAmerican-vs-Asian
1.737030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.607350E-01
Normal-vs-Female
1.356360E-02
Male-vs-Female
6.710000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.367200E-01
Normal-vs-Age(41-60Yrs)
2.968200E-01
Normal-vs-Age(61-80Yrs)
1.436970E-01
Normal-vs-Age(81-100Yrs)
2.457200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.448000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.927200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.118400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.330400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.527600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.748400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.256300E-02
Normal-vs-Daily Drinker
1.930610E-01
Normal-vs-Weekly Drinker
1.559650E-02
Normal-vs-Occasional Drinker
8.744400E-02
Normal-vs-Social Drinker
1.790810E-01
Non Drinker-vs-Daily Drinker
4.219600E-01
Non Drinker-vs-Weekly Drinker
8.525800E-01
Non Drinker-vs-Occasional Drinker
3.927400E-01
Non Drinker-vs-Social Drinker
1.697630E-01
Daily Drinker-vs-Weekly Drinker
5.626200E-01
Daily Drinker-vs-Occasional Drinker
1.024040E-01
Daily Drinker-vs-Social Drinker
5.488200E-02
Weekly Drinker-vs-Occasional Drinker
3.477000E-01
Weekly Drinker-vs-Social Drinker
1.619830E-01
Occasional Drinker-vs-Social Drinker
6.048600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.595000E-01
Normal-vs-Grade 2
2.315600E-01
Normal-vs-Grade 3
1.163390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.245430E-01
Grade 1-vs-Grade 3
1.672200E-01
Grade 1-vs-Grade 4
3.595000E-01
Grade 2-vs-Grade 3
6.957800E-01
Grade 2-vs-Grade 4
2.315600E-01
Grade 3-vs-Grade 4
1.163390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.322400E-02
Normal-vs-NonDiabetic
1.861860E-02
Diabetic-vs-NonDiabetic
7.012800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.579670E-02
Normal-vs-NoPancreatitis
2.467700E-02
Pancreatitis-vs-NoPancreatitis
2.461800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.367600E-02
Normal-vs-N1
8.703600E-02
N0-vs-N1
8.003200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.852300E-02
Normal-vs-TP53-NonMutant
3.651400E-01
TP53-Mutant-vs-TP53-NonMutant
7.376500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
